Progress in Pediatric Cardiology
Volume 21, Issue 2 , Pages 219-225 , March 2006

Extracellular matrix scaffolds for tissue engineering heart valves

  • Patricia M. Taylor

      Affiliations

    • Heart Science Centre, Harefield Hospital, National Heart and Lung Institute, Imperial College London, Harefield, Middlesex, UB9 6JH, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 1895 828889; fax: +44 1895 828900.
  • ,
  • Anthony E.G. Cass

      Affiliations

    • Institute of Biomedical Engineering, Sherfield Building (Level 5), Imperial College London, South Kensington Campus, London, SW7 2AZ, UK
  • ,
  • Magdi H. Yacoub

      Affiliations

    • Heart Science Centre, Harefield Hospital, National Heart and Lung Institute, Imperial College London, Harefield, Middlesex, UB9 6JH, UK

References 

  1. Yacoub MH, Kilner PJ, Birks EJ, Misfeld M. The aortic outflow and root: a tale of dynamism and crosstalk. Ann Thorac Surg. 1999;68(3 Suppl):S37–S43
  2. Yacoub MH, Takkenberg JJM. Will heart valve tissue engineering change the world?. Nat Clin Pract Cardiovasc Med. 2005;2(2):60–61
  3. Hentz VR, Chang J. Tissue engineering for reconstruction of the thumb. N Engl J Med. 2001;344(20):1547–1548
  4. Yacoub MH, Cohn LH. Novel approaches to cardiac valve repair: from structure to function: Part I. Circulation. 2004;109(8):942–950
  5. Bashey RI, Torii S, Angrist A. Age-related collagen and elastin content of human heart valves. J Gerontol. 1967;22(2):203–208
  6. Scott MJ, Vesely I. Morphology of porcine aortic valve cusp elastin. J Heart Valve Dis. 1996;5(5):464–471
  7. Vesely I, Lozon A. Natural preload of aortic valve leaflet components during glutaraldehyde fixation: effects on tissue mechanics. J Biomech. 1993;26(2):121–131
  8. Scott M, Vesely I. Aortic valve cusp microstructure: the role of elastin. Ann Thorac Surg. 1995;60(2 Suppl):S391–S394
  9. Vesely I. The role of elastin in aortic valve mechanics. J Biomech. 1998;31(2):115–123
  10. Johnson NA, Sengupta S, Saidi SA, et al. Endothelial cells preparing to die by apoptosis initiate a program of transcriptome and glycome regulation. FASEB J. 2004;18(1):188–190
  11. Bairati A, DeBiasi S. Presence of a smooth muscle system in aortic valve leaflets. Anat Embryol (Berl). 1981;161(3):329–340
  12. Konig K, Schenke-Layland K, Riemann I, Stock UA. Multiphoton autofluorescence imaging of intratissue elastic fibers. Biomaterials. 2005;26(5):495–500
  13. Schenke-Layland K, Riemann I, Stock UA, Konig K. Imaging of cardiovascular structures using near-infrared femtosecond multiphoton laser scanning microscopy. J Biomed Opt. 2005;10(2):024017
  14. Latif N, Sarathchandra P, Taylor PM, Antoniw J, Yacoub MH. Localization and pattern of expression of extracellular matrix components in human heart valves. J Heart Valve Dis. 2005;14(2):218–227
  15. Chester AH, Misfeld M, Yacoub MH. Receptor-mediated contraction of aortic valve leaflets. J Heart Valve Dis. 2000;9(2):250–254
  16. Chester AH, Misfeld M, Sievers HH, Yacoub MH. Influence of 5-hydroxytryptamine on aortic valve competence in vitro. J Heart Valve Dis. 2001;10(6):822–825
  17. Kershaw JD, Misfeld M, Sievers HH, Yacoub MH, Chester AH. Specific regional and directional contractile responses of aortic cusp tissue. J Heart Valve Dis. 2004;13(5):798–803
  18. Deck JD, Thubrikar MJ, Schneider PJ, Nolan SP. Structure, stress, and tissue repair in aortic valve leaflets. Cardiovasc Res. 1988;22(1):7–16
  19. Thubrikar MJ, Aouad J, Nolan SP. Comparison of the in vivo and in vitro mechanical properties of aortic valve leaflets. J Thorac Cardiovasc Surg. 1986;92(1):29–36
  20. Stock UA, Nagashima M, Khalil PN, et al. Tissue-engineered valved conduits in the pulmonary circulation. J Thorac Cardiovasc Surg. 2000;119(4 Pt 1):732–740
  21. Sodian R, Hoerstrup SP, Sperling JS, et al. Early in vivo experience with tissue-engineered trileaflet heart valves. Circulation. 2000;102(19 Suppl 3):III22–III29
  22. Hoerstrup SP, Sodian R, Daebritz S, et al. Functional living trileaflet heart valves grown in vitro. Circulation. 2000;102(19 Suppl 3):III44–III49
  23. Sutherland FW, Perry TE, Yu Y, et al. From stem cells to viable autologous semilunar heart valve. Circulation. 2005;111(21):2783–2791
  24. Ye Q, Zund G, Jockenhoevel S, et al. Scaffold precoating with human autologous extracellular matrix for improved cell attachment in cardiovascular tissue engineering. ASAIO J. 2000;46(6):730–733
  25. ffrench-Constant C, Colognato H. Integrins: versatile integrators of extracellular signals. Trends Cell Biol. 2004;14(12):678–686
  26. Humphries MJ, Travis MA, Clark K, Mould AP. Mechanisms of integration of cells and extracellular matrices by integrins. Biochem Soc Trans. 2004;32(Pt 5):822–825
  27. Latif N, Sarathchandra P, Taylor PM, Antoniw J, Yacoub MH. Molecules mediating cell–ECM and cell–cell communication in human heart valves. Cell Biochem Biophys. 2005;43(2):275–288
  28. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell. 2002;110:673–687
  29. McCawley LJ, Matrisian LM. Matrix metalloproteinases: they're not just for matrix anymore!. Curr Opin Cell Biol. 2001;13(5):534–540
  30. Comoglio PM, Boccaccio C, Trusolino L. Interactions between growth factor receptors and adhesion molecules: breaking the rules. Curr Opin Cell Biol. 2003;15(5):565–571
  31. Chevallay B, Herbage D. Collagen-based biomaterials as 3D scaffold for cell cultures: applications for tissue engineering and gene therapy. Med Biol Eng Comput. 2000;38(2):211–218
  32. Taylor PM, Allen SP, Dreger SA, Yacoub MH. Human cardiac valve interstitial cells in collagen sponge: a biological three-dimensional matrix for tissue engineering. J Heart Valve Dis. 2002;11(3):298–306
  33. Rothenburger M, Vischer P, Volker W, et al. In vitro modelling of tissue using isolated vascular cells on a synthetic collagen matrix as a substitute for heart valves. Thorac Cardiovasc Surg. 2001;49(4):204–209
  34. Rothenburger M, Volker W, Vischer P, Glasmacher B, Scheld HH, Deiwick M. Ultrastructure of proteoglycans in tissue-engineered cardiovascular structures. Tissue Eng. 2002;8(6):1049–1056
  35. Rothenburger M, Volker W, Vischer JP, et al. Tissue engineering of heart valves: formation of a three-dimensional tissue using porcine heart valve cells. ASAIO J. 2002;48(6):586–591
  36. Sachlos E, Reis N, Ainsley C, Derby B, Czernuszka JT. Novel collagen scaffolds with predefined internal morphology made by solid freeform fabrication. Biomaterials. 2003;24(8):1487–1497
  37. Badylak SF, Record R, Lindberg K, Hodde J, Park K. Small intestinal submucosa: a substrate for in vitro cell growth. J Biomater Sci Polym Ed. 1998;9(8):863–878
  38. Matheny RG, Hutchison ML, Dryden PE, Hiles MD, Shaar CJ. Porcine small intestine submucosa as a pulmonary valve leaflet substitute. J Heart Valve Dis. 2000;9(6):769–774
  39. Ruiz CE, Iemura M, Medie S, et al. Transcatheter placement of a low-profile biodegradable pulmonary valve made of small intestinal submucosa: a long-term study in a swine model. J Thorac Cardiovasc Surg. 2005;130(2):477–484
  40. Ye Q, Zund G, Benedikt P, et al. Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur J Cardiothorac Surg. 2000;17(5):587–591
  41. Jockenhoevel S, Chalabi K, Sachweh JS, et al. Tissue engineering: complete autologous valve conduit—a new moulding technique. Thorac Cardiovasc Surg. 2001;49(5):287–290
  42. Jockenhoevel S, Zund G, Hoerstrup SP, et al. Fibrin gel—advantages of a new scaffold in cardiovascular tissue engineering. Eur J Cardiothorac Surg. 2001;19(4):424–430
  43. Schense JC, Hubbell JA. Cross-linking exogenous bifunctional peptides into fibrin gels with factor XIIIa. Bioconjug Chem. 1999;10(1):75–81
  44. Ye Q, Zund G, Jockenhoevel S, et al. Tissue engineering in cardiovascular surgery: new approach to develop completely human autologous tissue. Eur J Cardiothorac Surg. 2000;17(4):449–454
  45. Hoerstrup SP, Zund G, Cheng S, et al. A new approach to completely autologous cardiovascular tissue in humans. ASAIO J. 2002;48(3):234–238
  46. Turley EA, Noble PW, Bourguignon LY. Signaling properties of hyaluronan receptors. J Biol Chem. 2002;277(7):4589–4592
  47. Masters KS, Shah DN, Walker G, Leinwand LA, Anseth KS. Designing scaffolds for valvular interstitial cells: cell adhesion and function on naturally derived materials. J Biomed Mater Res A. 2004;71(1):172–180
  48. Masters KS, Shah DN, Leinwand LA, Anseth KS. Crosslinked hyaluronan scaffolds as a biologically active carrier for valvular interstitial cells. Biomaterials. 2005;26(15):2517–2525
  49. Ramamurthi A, Vesely I. Evaluation of the matrix-synthesis potential of crosslinked hyaluronan gels for tissue engineering of aortic heart valves. Biomaterials. 2005;26(9):999–1010
  50. Daly R, Hearn MT. Expression of heterologous proteins in Pichia pastoris: a useful experimental tool in protein engineering and production. J Mol Recognit. 2005;18(2):119–138
  51. Zakrzewska M, Krowarsch D, Wiedlocha A, Otlewski J. Design of fully active FGF-1 variants with increased stability. Protein Eng Des Sel. 2004;17(8):603–611
  52. Lauffenburger DA, Fallon EM, Haugh JM. Scratching the (cell) surface: cytokine engineering for improved ligand/receptor trafficking dynamics. Chem Biol. 1998;5(10):R257–R263
  53. Wada A, Mie M, Aizawa M, Lahoud P, Cass AE, Kobatake E. Design and construction of glutamine binding proteins with a self-adhering capability to unmodified hydrophobic surfaces as reagentless fluorescence sensing devices. J Am Chem Soc. 2003;125(52):16228–16234
  54. Zisch AH, Zeisberger SM, Ehrbar M, et al. Engineered fibrin matrices for functional display of cell membrane-bound growth factor-like activities: study of angiogenic signaling by ephrin-B2. Biomaterials. 2004;25(16):3245–3257
  55. Xia Y, Whitesides G. Soft lithography. Annu Rev Mat Sci. 1998;28:153–184
  56. Silva GA, Czeisler C, Niece KL, et al. Selective differentiation of neural progenitor cells by high-epitope density nanofibers. Science. 2004;303(5662):1352–1355
  57. Verreck G, Chun I, Peeters J, Rosenblatt J, Brewster ME. Preparation and characterization of nanofibers containing amorphous drug dispersions generated by electrostatic spinning. Pharm Res. 2003;20(5):810–817
  58. Taylor PM, Sachlos E, Dreger SA, Chester AH, Czernuszka JT, Yacoub MH. Interaction of human valve interstitial cells with collagen matrices manufactured using rapid prototyping. Biomaterials [in press].

PII: S1058-9813(05)00088-3

doi: 10.1016/j.ppedcard.2005.11.010

Progress in Pediatric Cardiology
Volume 21, Issue 2 , Pages 219-225 , March 2006